PTGX R&D Expense Growth
Protagonist Therapeutics Inc · R&D Expense Growth
PTGX R&D Expense Growth
Latest reported15.32%period ending
PTGX FY R&D Growth (YoY) (0.00% → 15.32%)
Latest values, visible window
High-resolution chart · PNG
PTGX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 15.3206% | |
| 14.9524% | |
| -4.7966% | |
| 0.1659% | |
| 65.8323% | |
| 16.8931% | |
| 9.2542% | |
| 28.8344% | |
| 79.6577% | |
| 117.2682% | |
| 58.6138% | |
| 0% |